Position in SCLX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$70
+$11 QoQ
Shares Held
9
-35.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 72 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026State of Wyoming holds $4,618,055 across 12 Drug Manufacturers - General names. SCLX ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,327 | $1,591,643 | |
| 2 | BIIB |
Biogen Inc.
|
2,923 | $631,543 | |
| 3 | JNJ |
Johnson & Johnson
|
2,006 | $509,463 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
7,237 | $416,995 | |
| 5 | GRFS |
Grifols SA
|
55,808 | $395,120 | |
| 6 | ABBV |
AbbVie Inc.
|
1,472 | $370,414 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,066 | $265,481 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,509 | $190,647 |
All Filings in SCLX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70 | 9 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $59 | 9 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $109 | 9 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $177 | 9 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $53 | 9 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $32,653 | 131,139 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $60,757 | 142,624 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $117,917 | 127,478 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $143,788 | 74,502 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $38,471 | 24,196 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $101,745 | 49,875 | Shares | Sole | 2024-02-15 | |
| No filing history on record for this holder in this stock. | ||||||